Dr. Mark Barakat discusses developments in gene therapy for neovascular AMD April 21, 2023/in Media/Press, UncategorizedWatch Dr. Mark Barakat discuss the suprachoroidal delivery of a tyrosinase kinase inhibitor and a gene therapy agent for the treatment of neovascular AMD.